Skip to main navigation Skip to main content Skip to page footer

The STOPSTORM Beneficiaries

A European network of leading experts.

Together, the STOPSTORM consortium paves the way to consensus and future late stage clinical trials for stereotactic arrhythmia radioablation (STAR). This project, initiated by the University Medical Centre Utrecht and coordinated since January 2024 by Christian-Albrechts-Universität zu Kiel, brings together clinical and technical expertise in catheter ablation and SAbR/SbRT and/or STAR treatment, and all have the willingness to collaborate on a European level to bring STAR to clinical practice. It is very important to include patient representative organisation as an active member of our consortium who sets up the STOPSTORM Patient Advisory Board. That is why Harteraad, the Dutch center of expertise for living with cardiovascular disease, participates in this project. 

Below you will find a link to our partner pages, where you can read more about their roles in the project, key personnel and relevant publications.